Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Henderson

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Respirology Case Reports|November 29, 2023
Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmasIeuan E S Evans, Shanal Kumar, Megan France, et al.
Clinical and Translational Radiation Oncology|November 4, 2020
Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trialLuke Nicholls, Yae-Eun Suh, Ewan Chapman, et al.
BMJ Open Respiratory Research|December 25, 2025
Non-tuberculous mycobacterial infection in cystic fibrosis before and after initiation of elexacaftor/tezacaftor/ivacaftor: now is not the time to lower the guardIeuan Edward Shepherd Evans, Daniel Smith, Daniel Henderson, et al.
ANZ Journal of Surgery|June 7, 2018
Prostate-specific membrane antigen avidity on positron emission tomography scan in malignant pleural mesotheliomaSiyaguna K D M Ekanayake, Ian A Yang, David B Godbolt, et al.
Applied Clinical Informatics|November 26, 2020
Remote Patient Monitoring Program for Hospital Discharged COVID-19 PatientsWilliam J Gordon, Daniel Henderson, Avital DeSharone, et al.
Ethnicity & Health|April 30, 2026
Culturally and linguistically diverse experiences of chronic pain in Australia: a qualitative synthesisAmanuiel Taddese, Leanne Bisset, David Chua, et al.
International Journal of Radiation Oncology, Biology, Physics|January 13, 2026
2-year outcomes of the SPARC phase II trial: Simultaneous focal boost with stereotactic radiotherapy for localised intermediate to high-risk prostate cancerBinnaz Yasar, Yae-Eun Suh, Ewan Chapman, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2024
Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 TrialBinnaz Yasar, Yae-Eun Suh, Ewan Chapman, et al.
European Urology|July 21, 2015
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional AnalysisPiet Ost, Barbara Alicja Jereczek-Fossa, Nicholas Van As, et al.
Frontiers in Oncology|May 21, 2019
Utility of Multi-Parametric Quantitative Magnetic Resonance Imaging for Characterization and Radiotherapy Response Assessment in Soft-Tissue Sarcomas and Correlation With HistopathologyJessica M Winfield, Aisha B Miah, Dirk Strauss, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Respirology Case Reports|November 29, 2023
Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmasIeuan E S Evans, Shanal Kumar, Megan France, et al.
Clinical and Translational Radiation Oncology|November 4, 2020
Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trialLuke Nicholls, Yae-Eun Suh, Ewan Chapman, et al.
BMJ Open Respiratory Research|December 25, 2025
Non-tuberculous mycobacterial infection in cystic fibrosis before and after initiation of elexacaftor/tezacaftor/ivacaftor: now is not the time to lower the guardIeuan Edward Shepherd Evans, Daniel Smith, Daniel Henderson, et al.
ANZ Journal of Surgery|June 7, 2018
Prostate-specific membrane antigen avidity on positron emission tomography scan in malignant pleural mesotheliomaSiyaguna K D M Ekanayake, Ian A Yang, David B Godbolt, et al.
Applied Clinical Informatics|November 26, 2020
Remote Patient Monitoring Program for Hospital Discharged COVID-19 PatientsWilliam J Gordon, Daniel Henderson, Avital DeSharone, et al.
Ethnicity & Health|April 30, 2026
Culturally and linguistically diverse experiences of chronic pain in Australia: a qualitative synthesisAmanuiel Taddese, Leanne Bisset, David Chua, et al.
International Journal of Radiation Oncology, Biology, Physics|January 13, 2026
2-year outcomes of the SPARC phase II trial: Simultaneous focal boost with stereotactic radiotherapy for localised intermediate to high-risk prostate cancerBinnaz Yasar, Yae-Eun Suh, Ewan Chapman, et al.
International Journal of Radiation Oncology, Biology, Physics|March 18, 2024
Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 TrialBinnaz Yasar, Yae-Eun Suh, Ewan Chapman, et al.
European Urology|July 21, 2015
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional AnalysisPiet Ost, Barbara Alicja Jereczek-Fossa, Nicholas Van As, et al.
Frontiers in Oncology|May 21, 2019
Utility of Multi-Parametric Quantitative Magnetic Resonance Imaging for Characterization and Radiotherapy Response Assessment in Soft-Tissue Sarcomas and Correlation With HistopathologyJessica M Winfield, Aisha B Miah, Dirk Strauss, et al.
Pageof 4